Showing results (31-40 of 1,431) with videos related to
Sort By:
Pageof 144
Oncogene|June 12, 2013
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approachesT Karantanos, P G Corn, T C ThompsonThe Journal of Urology|May 23, 1998
Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic studyO Z Hampel, M W Kattan, G Yang, et al.Human Gene Therapy|March 1, 1996
Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer modelsJ A Eastham, S H Chen, I Sehgal, et al.Gene Therapy|April 23, 2011
Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer modelK Tabata, S Kurosaka, M Watanabe, et al.Oncogene|March 2, 1995
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancerT C Thompson, S H Park, T L Timme, et al.Prostate Cancer and Prostatic Diseases|March 11, 2003
Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promotersS Ebara, S Shimura, Y Nasu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoterC Pramudji, S Shimura, S Ebara, et al.Cancer Research|June 5, 2001
Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cellsL Li, G Yang, S Ebara, et al.Cell|March 24, 1989
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organT C Thompson, J Southgate, G Kitchener, et al.Cancer Research|April 15, 2000
Resistance to lysis by cytotoxic T cells: a dominant effect in metastatic mouse prostate cancer cellsH M Lee, T L Timme, T C ThompsonPageof 144